Unknown

Dataset Information

0

Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes.


ABSTRACT: Cannabinoid receptor 2 (CB2) is a promising therapeutic target for immunological modulation. There is, however, a deficit of knowledge regarding CB2 signaling and function in human primary immunocompetent cells. We applied an experimental paradigm which closely models the in situ state of human primary leukocytes (PBMC; peripheral blood mononuclear cells) to characterize activation of a number of signaling pathways in response to a CB2-selective ligand (HU308). We observed a "lag" phase of unchanged cAMP concentration prior to development of classically expected Gαi-mediated inhibition of cAMP synthesis. Application of G protein inhibitors revealed that this apparent lag was a result of counteraction of Gαi effects by concurrent Gαs activation. Monitoring downstream signaling events showed that activation of p38 was mediated by Gαi, whereas ERK1/2 and Akt phosphorylation were mediated by Gαi-coupled βγ. Activation of CREB integrated multiple components; Gαs and βγ mediated ∼85% of the response, while ∼15% was attributed to Gαi. Responses to HU308 had an important functional outcome-secretion of interleukins 6 (IL-6) and 10 (IL-10). IL-2, IL-4, IL-12, IL-13, IL-17A, MIP-1α, and TNF-α were unaffected. IL-6/IL-10 induction had a similar G protein coupling profile to CREB activation. All response potencies were consistent with that expected for HU308 acting via CB2. Additionally, signaling and functional effects were completely blocked by a CB2-selective inverse agonist, giving additional evidence for CB2 involvement. This work expands the current paradigm regarding cannabinoid immunomodulation and reinforces the potential utility of CB2 ligands as immunomodulatory therapeutics.

SUBMITTER: Saroz Y 

PROVIDER: S-EPMC7088898 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cannabinoid Receptor 2 (CB<sub>2</sub>) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes.

Saroz Yurii Y   Kho Dan T DT   Glass Michelle M   Graham Euan Scott ES   Grimsey Natasha Lillia NL  

ACS pharmacology & translational science 20191001 6


Cannabinoid receptor 2 (CB<sub>2</sub>) is a promising therapeutic target for immunological modulation. There is, however, a deficit of knowledge regarding CB<sub>2</sub> signaling and function in human primary immunocompetent cells. We applied an experimental paradigm which closely models the <i>in situ</i> state of human primary leukocytes (PBMC; peripheral blood mononuclear cells) to characterize activation of a number of signaling pathways in response to a CB<sub>2</sub>-selective ligand (HU  ...[more]

Similar Datasets

| S-EPMC1573900 | biostudies-literature
| S-EPMC3918582 | biostudies-literature
| PRJEB59180 | ENA
| S-EPMC3096817 | biostudies-other
| S-EPMC3388033 | biostudies-literature
| S-EPMC1334629 | biostudies-literature
| S-EPMC5337865 | biostudies-other
| S-EPMC2964726 | biostudies-literature
| S-EPMC6713262 | biostudies-literature
| S-EPMC9041759 | biostudies-literature